Menu
Not yet recruiting NCT07742189

Medication Collaboration Feasibility Study

No phase Interventional Dementia Family Caregiver Dementia Medication Adherence

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Medication Collaboration Intervention.
Who it may be relevant to
Registry conditions: Dementia Family Caregiver, Dementia, Medication Adherence. Basic parameters: from 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Feasibility Study of a Brief Intervention to Support Medication Collaboration Among Older Adults and Family Care Partners

Overview

This study examines the feasibility and acceptability of a brief medication collaboration intervention among older adults (age 60+) with early-stage dementia or mild cognitive impairment who take multiple medications and their family caregivers. The main aims are to: 1) determine the feasibility and acceptability of the intervention for older adults with early-stage dementia and their family caregivers, and 2) explore the effects of intervention on medication collaboration, medication adherence, and beliefs about dementia and autonomy. In this study, participants will: 1) complete a 15-30-minute baseline interview (by Zoom or phone), 2) participate together in a 45-60-minute virtual intervention led by an interventionist that includes: Assessment of medication responsibilities and beliefs. Education about dementia and medication management. Cognitive restructuring to address beliefs about independence and caregiver assistance. Collaborative planning for medication responsibilities and routines; and lastly 3) complete a 15-20-minute one-month follow-up interview (by Zoom or phone) to assess the intervention's acceptability and changes in medication management outcomes.

Interventions

  • Behavioral Medication Collaboration Intervention
    A brief virtual behavioral intervention for older adults with early-stage dementia and their family caregivers designed to support collaborative medication management. The intervention includes: (1) assessment of beliefs about dementia, autonomy, and current medication responsibilities; (2) education on dementia progression and medication management; (3) reframing maladaptive beliefs regarding independence and caregiver assistance; and (4) collaborative development of implementation intentions a

Primary outcome measures

  • Acceptability of the Medication Collaboration Intervention [Time frame: 1 Month]
Secondary outcome measures (5)
  • Medication Collaboration [Time frame: 1 Month]
  • Medication adherence [Time frame: 1 Month]
  • Beliefs about dementia [Time frame: 1 month]
  • Medication Administration Hassles [Time frame: 1 Month]
  • Beliefs about independence with medicines [Time frame: 1 month]

Eligibility criteria

Inclusion Criteria for older adults with dementia:

  • Age 60 or older
  • Diagnosis of dementia, Alzhimer's Disease or Mild Cognitive Impairment
  • Quick Dementia Rating Scale Score 2-12 (inclusive of mild cognitive impairment and mild dementia)
  • Taking 3 or more medications
  • Involved with managing their medications
  • Proficient speaking English
  • Capacity to provide consent

Inclusion criteria for caregivers include::

  • Primary family caregiver for the past 3 months
  • Age 18 or older
  • Proficient speaking English

Exclusion criteria

  • adults unable to consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Supportive care

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07742189 · STU00226320

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗